Page last updated: 2024-08-23

phenyl acetate and Hypertrophy, Right Ventricular

phenyl acetate has been researched along with Hypertrophy, Right Ventricular in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Calderone, A; Daneault, C; Dupuis, J; Fen Shi, Y; Gagnon, L; Grouix, B; Laurin, P; Nguyen, QT; Nsaibia, MJ; Ruiz, M; Sirois, MG; Tardif, JC1

Other Studies

1 other study(ies) available for phenyl acetate and Hypertrophy, Right Ventricular

ArticleYear
PBI-4050 reduces pulmonary hypertension, lung fibrosis, and right ventricular dysfunction in heart failure.
    Cardiovascular research, 2020, 01-01, Volume: 116, Issue:1

    Topics: Acetates; Animals; Cells, Cultured; Disease Models, Animal; Endothelin-1; Extracellular Signal-Regulated MAP Kinases; Fibroblasts; Fibrosis; Heart Failure; Heart Ventricles; Humans; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Interleukin-6; Lung; Male; Phosphorylation; Pulmonary Fibrosis; Rats, Wistar; Receptors, G-Protein-Coupled; Signal Transduction; Transforming Growth Factor beta; Ventricular Dysfunction, Right; Ventricular Function, Right; Ventricular Remodeling

2020